Amyloid Solution
Latest round
- Series C
Last raised
- May 2022
Total raised
- $59M
Investors
- 18
About Amyloid Solution
a. Amyloid Solution is a health technology company that focuses on discovering and providing effective, safe, and diverse therapeutic solutions to overcome Alzheimer's disease. The company collaborates with international and domestic biopharma industries and scientists to search for fundamental culprits, interpret systemic interactions, and discover methods for varied patient cases. As of December 2022, the company operates three programs, which are amyloid, immunity, and homeostasis. In May 2022, Amyloid Solution Inc.S. Investment. The company’s product line includes AS-S701, a small molecule drug that directly disaggregates all types of amyloid-ß aggregates, including oligomers and plaques, into non-toxic monomers; and AS-M801, a toll-like receptor-2 (TLR2) antagonistic monoclonal antibody to suppress the inflammatory response. Amyloid Solution also developing several other products, including S603, M302, N402, N403, and S204. Amyloid Solution Inc. In addition, the company will be collaborating with other drug tech companies to speed up the discovery of new targets and drug design.
Who invested in Amyloid Solution
18 investors across 4 rounds
See all investors in Amyloid Solution
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amyloid Solution
Who invested in Amyloid Solution?
Amyloid Solution has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amyloid Solution raised?
Amyloid Solution has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Amyloid Solution last raise money?
Amyloid Solution's most recent round on record is a Series C, in May 2022.
What does Amyloid Solution do?
Amyloid Solution is a biotechnology company.
Where is Amyloid Solution headquartered?
Amyloid Solution is headquartered in Seongnam, South Korea.
Which VCs invest in companies like Amyloid Solution?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Amyloid Solution's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Amyloid Solution? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.